Donna Catamero Discusses Managing Teclistamab-Induced CRS for Patients With Multiple Myeloma
Donna Catamero, ANP-BC, OCN, CCRC, outlines best management strategies for treating patients receiving teclistamab who experience cytokine release syndrome.
Second-Line Axi-Cel Bests HDT/HSCT in Prolonging Overall Survival in R/R LBCL
Erdafitinib Reduces Risk of Death by 36% in FGFR-Altered Urothelial Cancer
Nirogacestat Significantly Reduces Pain Severity in Patients With Desmoid Tumors
Dostarlimab Maintains HRQOL in 3-Year Follow-Up Of Patients With Early Endometrial Cancer
